We hypothesized that obesity would be particularly related to the development of less aggressive tumors (i.e. ER+, PR+, HER2-, Ki67low, Bcl-2+ and p53- tumors). Here, ERBB2 is linked to obesity due to melanocortin 4 receptor deficiency.